Skip to content

Multimodal Evaluation of Cartilage Lesions of Patellofemoral Joint

Multimodal Evaluation of Cartilage Lesions of Patellofemoral Joint

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03210584
Acronym
MULTICART
Enrollment
10
Registered
2017-07-07
Start date
2016-10-31
Completion date
2018-09-30
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

Knee joint, Cartilage degeneration, Ultrasound imaging, Full-Field Optical Coherence Tomography, 9,4 Tesla MRI, Multimodal evaluation

Brief summary

Evaluation and comparison of histological analysis, 9,4 tesla MRI, Full-Field Optical Coherence Tomography (FFOCT) and ultrasound-based navigation system for cartilage degeneration analysis of patellofemoral joint.

Detailed description

Knee osteoarthritis (OA) is a common and debilitating chronic degenerative disease of the articular cartilage. Despite recent progress in the field of cartilage imaging, no routinely used clinical imaging modality has the ability to evaluate and monitor changes in cartilage degeneration. This observationnal, pilot, prospective, non randomized, uncontrolled, monocentric study aim to compare three of the most innovative imaging systems, namely the 9,4 Tesla MRI, the FFOCT (Full-Field Optical Coherence Tomography) and the ultrasound-based navigation system in order to image healthly to severely degraded human cartilage samples. All methods will be cross-correlated and compared with histological data considered as the gold standard.

Interventions

None listed

Sponsors

Clinical Investigation Centre for Innovative Technology Network
CollaboratorNETWORK
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years of age * Knee prosthetic surgery indication with cartilage excision.

Exclusion criteria

* Subjects who refuse to sign a non-objection form

Design outcomes

Primary

MeasureTime frameDescription
Evaluation and comparison of histologic analysis, 9,4 Tesla MRI, FFOCT and ultrasound-based navigation system for cartilage lesions analysis of patellofemoral joint.6 monthsCorrelation between Osteoarthritis Research Society International (OARSI) grades performed for different modalities

Secondary

MeasureTime frameDescription
Evaluation of FFOCT reconstructions in early osteoarthritis evaluation using visual qualitative information parameter.6 monthsCorrelation between quantitative parameters from FFOCT and gold standard OARSI grade
Evaluation of navigation ultrasound in early osteoarthritis evaluation using visual qualitative information parameter.6 monthsCorrelation between quantitative parameters from navigation ultrasound and gold standard OARSI grade
Evaluation of of 9,4 Tesla MRI reconstruction in early osteoarthritis evaluation using visual quantitative information parameter obtained for the Average Pathlength Maps.6 monthsCorrelation between quantitative parameters from the Average Pathlength Maps and gold standard OARSI grade
Evaluation of 9,4 Tesla MRI reconstructions in early osteoarthritis evaluation using visual qualitative information parameter obtained from the Average Pathlength Maps (APM).6 monthsCorrelation between MRI quantitative parameters and gold standard OARSI grade
Evaluation of navigation ultrasound in early osteoarthritis evaluation using visual quantitative information parameter.6 monthsThickness average of cartilage
Inter-observer robustness analysis of the OARSI classification6 monthsInter-observers Kappa coefficient
Intra-observer robustness analysis of the OARSI classification6 monthsIntra-observers Kappa coefficient
Evaluation of FFOCT reconstructions in early osteoarthritis evaluation using visual quantitative information parameter.6 monthsThickness average of cartilage

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026